Results 211 to 220 of about 125,484 (349)

The association between proton pump inhibitors and the risk of gastrointestinal bleeding in oral anticoagulants users. [PDF]

NPJ Cardiovasc Health
Wang Z, Yu Q, Warren-Gash C, Bhaskaran K, Leyrat C, Cheung KS, Chui CSL, Chan EW, Wong ICK, Banerjee A, Smeeth L, Douglas IJ, Wong AYS.   +12 more
europepmc   +1 more source

Proton pump inhibitors in bleeding peptic ulcer: A meta-analysis

, 2000
Duane G. Sheppard, John Fardy
openalex   +1 more source

Intragastric acidification reduces the occurrence of false-negative urea breath test results in patients taking a proton pump inhibitor [PDF]

, 2001
William D. Chey
openalex   +1 more source

The safety of proton pump inhibitors [PDF]

Alimentary Pharmacology & Therapeutics, 2001
openaire   +3 more sources

Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: Cohort study [PDF]

, 2019
Al-Aly, Ziyad, Bowe, Benjamin, Li, Tingting, Xian, Hong, Xie, Yan, Yan, Yan   +5 more
core   +1 more source

Pharmacogenomics in the UK National Health Service: Progress towards implementation

British Journal of Clinical Pharmacology, EarlyView.
Over the past decade there has been considerable and growing enthusiasm about the promise of using genomics to inform healthcare. In particular, using genetic data to inform prescribing practice has emerged as a compelling policy priority for health systems around the world, not least in the NHS.
John H. McDermott, Maria Tsakiroglou, William G. Newman, Munir Pirmohamed   +3 more
wiley   +1 more source

Use of Proton Pump Inhibitors Among Patients With Alcohol-Related Cirrhosis-A Danish Nationwide Cohort Study. [PDF]

Liver Int
Ramsing MS, Jensen MD, Jepsen P.
europepmc   +1 more source

Prophylactic efficacy of the mucosal cytoprotective agent teprenone and the proton pump inhibitor rabeprazole against gastroduodenal lesions caused by piroxicam: controlled trial study.

, 2000
Akira Yanagawa, T. Endo, Yuko Murayama
openalex   +2 more sources

Proton pump inhibitors versus H₂‐antagonists: a meta‐analysis of their efficacy in treating bleeding peptic ulcer [PDF]

, 2001
Javier P. Gisbert, Leticia González, Xavier Calvet, Marta Roqué i Figuls, Rafael Gabriel, José Marı́a Pajares   +5 more
openalex   +1 more source

Artificial intelligence modelling of tyrosine kinase inhibitors at risk of malabsorption and bioavailability‐enhancing strategies

British Journal of Clinical Pharmacology, EarlyView.
Aims The study aims to predict and improve the absorption of tyrosine kinase inhibitors (TKIs) in patients with malabsorption issues, particularly those who have undergone bariatric surgery or are using proton‐pump inhibitors. The research involves 2 main components: the development of an artificial intelligence (AI) model to identify TKIs that are ...
Daan W. Huntjens, Olivier J. M. Béquignon, Stefanie D. Krens, Mark Löwenberg, Martine E. D. Chamuleau, Remco J. Molenaar, Anita M. G. Kramers, Marianne A. Kuijvenhoven, Imke H. Bartelink   +8 more
wiley   +1 more source